- Home
- BIOX vs COEP Comparison
BIOX vs COEP Comparison
Compare BIOX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- COEP
- Stock Information
- Founded
- BIOX 2001
- COEP 2017
- Country
- BIOX Argentina
- COEP United States
- Employees
- BIOX N/A
- COEP N/A
- Industry
- BIOX Agricultural Chemicals
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BIOX Industrials
- COEP Health Care
- Exchange
- BIOX Nasdaq
- COEP Nasdaq
- Market Cap
- BIOX 85.0M
- COEP 86.0M
- IPO Year
- BIOX N/A
- COEP N/A
- Fundamental
- Price
- BIOX $1.30
- COEP $16.76
- Analyst Decision
- BIOX Buy
- COEP
- Analyst Count
- BIOX 3
- COEP 0
- Target Price
- BIOX $4.50
- COEP N/A
- AVG Volume (30 Days)
- BIOX 647.6K
- COEP 65.4K
- Earning Date
- BIOX 11-10-2025
- COEP 11-12-2025
- Dividend Yield
- BIOX N/A
- COEP N/A
- EPS Growth
- BIOX N/A
- COEP N/A
- EPS
- BIOX N/A
- COEP N/A
- Revenue
- BIOX $333,300,000.00
- COEP $263,555.00
- Revenue This Year
- BIOX $6.77
- COEP N/A
- Revenue Next Year
- BIOX $21.39
- COEP N/A
- P/E Ratio
- BIOX N/A
- COEP N/A
- Revenue Growth
- BIOX N/A
- COEP N/A
- 52 Week Low
- BIOX $1.20
- COEP $2.31
- 52 Week High
- BIOX $7.81
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- BIOX 21.21
- COEP 60.80
- Support Level
- BIOX $1.20
- COEP $16.00
- Resistance Level
- BIOX $1.83
- COEP $18.15
- Average True Range (ATR)
- BIOX 0.15
- COEP 1.60
- MACD
- BIOX 0.02
- COEP 0.07
- Stochastic Oscillator
- BIOX 13.97
- COEP 66.80
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.